Assessment of vitamin D status in common variable immunodeficiency or ataxia-telangiectasia patients

Main Article Content

J.R.S. Cruz
R. Silva
I.G.A. Andrade
F.L.A. Fonseca
B.T. Costa-Carvalho
R.O.S. Sarni

Keywords

Vitamin D, Body composition, Ataxia-telangiectasia, Common variable immunodeficiency

Abstract

Introduction and objectives: Vitamin D plays a role in the immune system, however studies regarding this are scarce. This study aimed to evaluate the nutritional status of vitamin D in patients with Common Variable Immunodeficiency (CVID) or Ataxia- Telangiectasia (A-T) and to relate it to body composition, inflammatory and bone metabolism markers.


Patients and methods: This is a cross-sectional and controlled study involving 24 patients of both sexes (59.3% male), aged 8-56 years, with CVID (n = 15) or A-T (n = 9). The following variables were evaluated: body mass index (BMI), 25-hydroxyvitamin D (25 (OH) D), hepatic profile, parathormone, calcium, phosphorus, alkaline phosphatase, interleukin 6 and high-sensitivity C-reactive protein.


Results: The median age was 26.0 years. A deficiency of 25 (OH) D was found in four A-T patients (44%) and two CVID patients (13%). Nine patients with CVI (60%) and six with A-T (66.7%) were overweight and underweight, respectively. There was a negative correlation between vitamin D and fat mass in the CVID group, and vitamin D and BMI in the A-T group. Vitamin D was negatively associated with the percentage of total fat among the patients (ˇ 0.842, 95% CI: −1.5-0.17, p = 0.015), R 2 = 0.21, after adjusting for sex and age.


Conclusion: Vitamin D deficiency occurred in a quarter of the patients although there was no difference between the patient and the control group; without association with bone and inflammation biomarkers. The percentage of fat and BMI were negatively associated with the concentrations of 25 (OH) D.

Abstract 65 | PDF Downloads 128

References

1. Sharma D, Jindal A, Rawat A, Singh S. Approach to a child with primary immunodeficiency made simple. Indian Dermatol Online J. 2017;8:391-405.

2. Al-Herz W, Picard C, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies expert committee for primary immunodeficiency. Front Immunol. 2015;35:696-726.

3. Salzer U, Unger S, Warnatz K. Common variable immunodeficiency (ICV): exploring the multiple dimensions of a heterogeneous disease. Ann N Y Acad Sci. 2012;1250:41-9.

4. Bousfiha A, Jeddane L, Picard C, Aila F, Gaspar B, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38:129-43.

5. Milne RL. Variants in the ATM gene and breast cancer susceptibility. Genome Med. 2009;1:1-4.

6. Rothblum-Oviatt C, Wright J, Lefton-Greif M, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:1-21.

7. Holick M. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.

8. Ferreira GB, Vanherwegen AS, Eelen G, Gutiérrez AC, Van Lommel L, Marchal K, et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep. 2015;10:711-25.

9. Paulino T, Rafael M, Silva R, Santos-Valente EC, Souza FS, Sarni RO, et al. Vitamin D and primary immunodeficiencies. Br J Med Med Res. 2015;7:1035-8.

10. Ardeniz O, Avci CB, Sin A, Ozgen G, Gunsar F, Mete N, et al. Vitamin D deficiency in the absence of enteropathy in three cases with common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147:74-83.

11. Prayle AP, Bush A, Suri M, Bhatt J. Low vitamin D levels in children with ataxia-telangiectasia. Arch Dis Child. 2017;102:158-68.

12. Esid.org. European Society for Immunodeficiencies; 2018. Available from: https://esid.org/Education/Diagnostic-Criteria-PID [Internet; cited 17.02.18].

13. Marshall W, e Tanner J. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.

14. Marshall W, e Tanner J. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.

15. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organ Tech Rep Ser, vol. 854; 1995. p. 1-452. Geneva.

16. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-95.

17. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ.
2007;85:649-732.

18. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709-23.

19. Deurenberg P, Pieters JJ, Hautuast JG. The assessment of the body fat percentage by skinfold thickness measurement in childhood and young adolescent. Br J Nutr. 1990;63:293-303.

20. Lohman TG. Advances in body composition assessment: current issues in exercises science. Illinois: Human Kinetic Publisher; 1992.

21. Maffeis C, Banzato C, Talamin G, Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr. 2008;152:207-13.

22. Holick MF. Vitamin D status: measurement, interpretation and clinical application. Ann Epidemol. 2009;19:73-8.

23. Nissenkorn A, Levy-Shraga Y, Banet-Levi Y, Lahad A, Sarouk I, Modan-Moses D. Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. Pediatr Res. 2016;79:889-94.

24. Rasheed N, Wang X, Niu QT, Yeh J, Li B. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum Mol Genet. 2006;15:1938-48.

25. Hishiya A, Ito M, Aburatani H, Motoyama N, Ikeda K, Watanabe K. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation. Bone. 2005;37:497-503.

26. Baris S, Ozen A, Ercan H, Karakoc-Aydiner E, Cagan H, Ozdemir C, et al. Osteoporosis: an ignored complication of ICV. Pediatr Allergy Immunol. 2011;22:676-83.

27. Golzarand M, Hollis BW, Mirmiran P, Wagner CL, Shab-Bidar S. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018;72:1-12.

28. Silva R, dos Santos-Valente EC, Burim Scomparini F, Saccardo Sarni RO, Costa-Carvalho BT. The relationship between nutritional status, vitamin A and zinc levels and oxidative stress in patients with ataxia-telangiectasia. Allergol Immunopathol (Madr). 2014;42:329-35.

29. Screimshaw NS. Effect of infection on nutrient requirement. J Parenter Enter Nutr. 1991;15:589-600.

30. Lefton-Greif MA, Crawford TO, McGrath-Morrow S, Carson KA, Lederman HM. Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia. J Rare Dis. 2011;6:1-10.

31. Vieira DG, Costa-Carvalho BT, Hix S, da Silva R, Correia MS, Sarni RO. Higher cardiovascular risk in common variable immunodeficiency and X-linked agammaglobulinaemia patients. Ann Nutr Metab. 2015;66:237-41.

32. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4-12.

33. Walsh J, Bowles S, Evans A. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017;24:389-94.